Literature DB >> 18057171

Liver disease in erythropoietic protoporphyria: insights and implications for management.

A V Anstey1, R J Hift.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18057171      PMCID： PMC2750922          DOI： 10.1136/gut.2006.097576

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  113 in total

Review 1.  Erythropoietic protoporphyria: clinical aspects with emphasis on the skin.

Authors:  H Baart de la Faille; J C Bijlmer-Iest; J van Hattum; J Koningsberger; L H Rademakers; H van Weelden
Journal:  Curr Probl Dermatol       Date:  1991

2.  Ferrochelatase activities in patients with erythropoietic protoporphyria and their families.

Authors:  G Goerz; S Bunselmeyer; K Bolsen; N Y Schürer
Journal:  Br J Dermatol       Date:  1996-05       Impact factor: 9.302

3.  Liver failure in erythropoietic protoporphyria associated with choledocholithiasis and severe post-transplantation polyneuropathy.

Authors:  G Lock; A Holstege; A R Mueller; W Christe; M O Doss; J Schölmerich; P Neuhaus
Journal:  Liver       Date:  1996-06

4.  Recovery from hepatic decompensation in protoporphyria.

Authors:  C L Conley; J J Chisholm
Journal:  Johns Hopkins Med J       Date:  1979-12

5.  Blood exchange and transfusion therapy for acute cholestasis in protoporphyria.

Authors:  H J van Wijk; J van Hattum; H Baart de la Faille; J W van den Berg; A Edixhoven-Bosdijk; J H Wilson
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

6.  Hepatic complications of erythropoietic protoporphyria.

Authors:  R P Sarkany; P G Norris
Journal:  Br J Dermatol       Date:  1994-02       Impact factor: 9.302

Review 7.  [Severe liver failure in erythropoietic protoporphyria. A report of a case treated by liver transplantation].

Authors:  M Jiménez-Sáenz; A Caunedo-Alvarez; M Rojas; M Mata; J L Villar; A Piñar; J Herrerías-Gutiérrez
Journal:  Med Clin (Barc)       Date:  1999-07-10       Impact factor: 1.725

8.  Ferrochelatase consisting of wild-type and mutated subunits from patients with a dominant-inherited disease, erythropoietic protoporphyria, is an active but unstable dimer.

Authors:  Yoshiko Ohgari; Mari Sawamoto; Masayoshi Yamamoto; Hirao Kohno; Shigeru Taketani
Journal:  Hum Mol Genet       Date:  2004-12-01       Impact factor: 6.150

9.  Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease.

Authors:  S Tutois; X Montagutelli; V Da Silva; H Jouault; P Rouyer-Fessard; K Leroy-Viard; J L Guénet; Y Nordmann; Y Beuzard; J C Deybach
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

10.  Effect of bile acid hydroxylation on biliary protoporphyrin excretion in rat liver.

Authors:  M M Berenson; J J Garcia Marin; C Gunther
Journal:  Am J Physiol       Date:  1988-09
View more
  8 in total

Review 1.  Liver disease and erythropoietic protoporphyria: a concise review.

Authors:  María José Casanova-González; María Trapero-Marugán; E Anthony Jones; Ricardo Moreno-Otero
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

2.  Liver transplantation for acute-on-chronic liver failure from erythropoietic protoporphyria.

Authors:  Pyoung-Jae Park; Shin Hwang; Young-Il Choi; Young-Dong Yu; Gil-Chun Park; Sung-Won Jung; Sam-Youl Yoon; Gi-Won Song; Tae-Yong Ha; Sung-Gyu Lee
Journal:  Clin Mol Hepatol       Date:  2012-12-21

3.  Liver metabolomics in a mouse model of erythropoietic protoporphyria.

Authors:  Pengcheng Wang; Madhav Sachar; Grace L Guo; Amina I Shehu; Jie Lu; Xiao-Bo Zhong; Xiaochao Ma
Journal:  Biochem Pharmacol       Date:  2018-06-12       Impact factor: 5.858

Review 4.  Erythropoietic Protoporphyria and X-Linked Protoporphyria: pathophysiology, genetics, clinical manifestations, and management.

Authors:  Manisha Balwani
Journal:  Mol Genet Metab       Date:  2019-01-24       Impact factor: 4.797

5.  Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury.

Authors:  Naoyuki Fujimori; Michiharu Komatsu; Naoki Tanaka; Mai Iwaya; Hajime Nakano; Ayumi Sugiura; Tomoo Yamazaki; Soichiro Shibata; Yugo Iwaya; Takashi Muraki; Yuki Ichikawa; Takefumi Kimura; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
Journal:  Clin J Gastroenterol       Date:  2017-07-04

Review 6.  Protoporphyrin IX: the Good, the Bad, and the Ugly.

Authors:  Madhav Sachar; Karl E Anderson; Xiaochao Ma
Journal:  J Pharmacol Exp Ther       Date:  2015-11-20       Impact factor: 4.030

7.  Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.

Authors:  Jasmin Barman-Aksözen; Paulina C Wiek; Vijay B Bansode; Frank Koentgen; Judith Trüb; Pawel Pelczar; Paolo Cinelli; Xiaoye Schneider-Yin; Daniel Schümperli; Elisabeth I Minder
Journal:  Dis Model Mech       Date:  2017-01-12       Impact factor: 5.758

Review 8.  An overview of the cutaneous porphyrias.

Authors:  Robert Dawe
Journal:  F1000Res       Date:  2017-10-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.